HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brent A Morse Selected Research

Panitumumab (Vectibix)

1/2011A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brent A Morse Research Topics

Disease

4Neoplasms (Cancer)
12/2012 - 03/2010
1Vascular Remodeling
12/2012
1Rhabdomyosarcoma
12/2012
1Sarcoma (Soft Tissue Sarcoma)
12/2012
1Ewing Sarcoma (Sarcoma, Ewing)
12/2012
1Glioblastoma (Glioblastoma Multiforme)
03/2010
1Carcinoma (Carcinomatosis)
03/2010

Drug/Important Bio-Agent (IBA)

3CT-322IBA
12/2012 - 03/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012
1Epidermal Growth Factor (EGF)IBA
01/2011
1Fibronectins (Fibronectin)IBA
01/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011
1Cetuximab (Erbitux)FDA Link
01/2011
1ErbB Receptors (EGF Receptor)IBA
01/2011
1nimotuzumabIBA
01/2011
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2011
1Panitumumab (Vectibix)FDA Link
01/2011
1AntibodiesIBA
01/2011
1Sunitinib (Sutent)FDA Link
03/2010
1Phosphotransferases (Kinase)IBA
03/2010
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2010
1temsirolimusFDA Link
03/2010
1Sorafenib (BAY 43-9006)FDA Link
03/2010

Therapy/Procedure

3Therapeutics
12/2012 - 01/2011